Immunohistochemical studies are central to understanding the spatial and temporal distribution(s) of cells and antigens which function in dynamic processes such as occur in development and neoplasia. This option was reflected in the response to the analysis of need performed by the Scientific Council of the Cancer Institute of New Jersey (CINJ), in which our colleagues urged the establishment of a molecular cytogenetic and Immunohistochemistry shared resource. CINJ capitalized on the resources of the Robert Wood Johnson Medical School Department of Pathology and Laboratory Medicine and the Department of Pharmacology of Rutgers University to develop this resource and provide cost-efficient and rapid immunohistochemical assays for CINJ members, and to provide a state-of-the-art microdissection facility for molecular analysis of tumor specimens. The resource has the capabilities to localize the expression of proteins, the transcription of mRNA, and the presence of aberrant chromosomes within specified cell types in tumor specimens, and in cell lines. With the microdissection facility, CINJ members can more accurately analyze suspected genetic alterations in isolated tumor cells from patient tumor samples. The overall goal of the shared resource is to provide cost effective immunohistochemical technology for CINJ members. Specific objectives include: 1. To provide immunohistochemical localization of cells and antigens using well-characterized antibodies in normal and malignant tissues. 2. To define the conditions for novel, investigator-developed antibodies to successfully localize tissue antigens. 3. To provide conventional histologic processing and staining. 4. To procure pure cells from specific microscopic regions of tissue sections using microdissection for genetic analysis of isolated tumor cells from patient sample. The Immunohistochemistry Shared Resource is managed by Dr. Peter Amenta, an experienced pathologist and authority on immunohistochemical methodologies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA072720-05
Application #
6434922
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-03-09
Project End
2002-02-28
Budget Start
Budget End
Support Year
5
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
George, Blessy; Joy, Melanie S; Aleksunes, Lauren M (2018) Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood) 243:272-282
Paratala, Bhavna S; Chung, Jon H; Williams, Casey B et al. (2018) RET rearrangements are actionable alterations in breast cancer. Nat Commun 9:4821
Jian-Yu E; Graber, Judith M; Lu, Shou-En et al. (2018) Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis. Curr Med Chem 25:2595-2607
Moloughney, Joseph G; Vega-Cotto, Nicole M; Liu, Sharon et al. (2018) mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. J Biol Chem 293:16464-16478
Zhu, Sining; Jin, Juan; Gokhale, Samantha et al. (2018) Genetic Alterations of TRAF Proteins in Human Cancers. Front Immunol 9:2111
Perekatt, Ansu O; Shah, Pooja P; Cheung, Shannon et al. (2018) SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res 78:4878-4890
Llanos, Adana A M; Tsui, Jennifer; Rotter, David et al. (2018) Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women. BMC Womens Health 18:162
Hadigol, Mohammad; Khiabanian, Hossein (2018) MERIT reveals the impact of genomic context on sequencing error rate in ultra-deep applications. BMC Bioinformatics 19:219
Severson, Eric A; Riedlinger, Gregory M; Connelly, Caitlin F et al. (2018) Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens. Blood 131:2501-2505
Shih, Weichung Joe; Lin, Yong (2018) Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers. Stat Med 37:687-709

Showing the most recent 10 out of 775 publications